Silihan lan utang jangka dawa perusahaan Profound Medical Corp. (PROF)

Simbol resmi perusahaan Profound Medical Corp (PROF)

Profound Medical Corp. (PROF) dominates its niche thanks to the unique TULSA-PRO system, which ensures high margins due to low demand elasticity. This price chart illustrates the dynamics of an asset whose debt load stands at 0.00. The company's production capacities are operating at maximum capacity with equipment in excellent condition. However, slow insurance reimbursement and pressure from global behemoths are hindering growth.

PROF (Profound Medical Corp) riwayat Utang jangka dawa perusahaan saka 04.07.2022 nganti 28.10.2026
Produk seri Profound Medical

This indicator aggregates liabilities with maturities exceeding one year, reflecting the long-term financing structure and operational resilience. An increase in this metric signals a credit burden, while a decrease confirms financial autonomy. For Profound Medical Corp. (PROF), with its patent-protected TULSA technology, debt control is critical to sustaining expansion without the risk of default. By analyzing the company's long-term debt history, an investor can determine the balance between leverage and its technological moat.

Perusahaan pesaing

dexcom.com - Utang jangka dawa|Utang jangka dawa perusahaan Penumbra (PEN)|NOVT - Silihan lan utang jangka dawa perusahaan|HAE: Utang jangka dawa perusahaan|INSP (Inspire Medical Systems Inc) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan PROCEPT BioRobotics PRCT|Kewajiban jangka dawa conmed.com|Pulse Biosciences - Utang jangka dawa perusahaan|Utang jangka dawa InMode Ltd INMD|Kewajiban jangka dawa perusahaan PMI (Picard Medical Inc.)|SRDX - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Senseonics Holdings, Inc. SENS|NPCE - Gedhene kewajiban jangka dawa|tactilemedical.com - Utang jangka dawa perusahaan|SANUWAVE Health (SNWV) - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan OM|Kewajiban jangka dawa perusahaan Electromed Inc (ELMD)|LENSAR, Inc. (LNSR) - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan RCEL (avitamedical.com)|Baird Medical - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan EDAP TMS SA EDAP|APYX (Bovie Medical) - Utang jangka dawa perusahaan|ICCM - Utang jangka dawa|Utang jangka dawa perusahaan pulmonx.com|TELA Bio (TELA) - Tanggungan utang jangka dawa perusahaan|CTSO: Utang jangka dawa perusahaan|Gunggunge utang jangka dawa Sensus Healthcare Inc|Utang jangka dawa perusahaan ZYXI (Zynex Inc)|Kewajiban jangka dawa perusahaan electrocore.com (ECOR)|Utang jangka dawa perusahaan RBOT (Vicarious Surgical)|Inspira Technologies Oxy B.H.N. Ltd. - Utang jangka dawa perusahaan|ICU - Utang jangka dawa perusahaan|IRIDEX Corporation (IRIX) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan ibs.inc INBS|Beyond Air (XAIR) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan PFSA (Profusa Inc)|Utang jangka dawa SSKN|GCTK: Utang jangka dawa perusahaan|Tanggungan jangka dawa NanoVibronix Inc. NAOV|Kewajiban jangka dawa perusahaan VERO (Venus Concept Corp)|Utang jangka dawa perusahaan Nuwellis Corp NUWE|Utang jangka dawa perusahaan AEMD (Aethlon Medical)|ASXC: Gunggunge utang jangka dawa|Utang jangka dawa perusahaan Avinger (AVGR)|BSGM (biosig.com) - Kewajiban jangka dawa|Utang jangka dawa perusahaan CUTR|Kewajiban jangka dawa perusahaan Know Labs Corporation|Inari Medical, Inc. - Utang jangka dawa perusahaan|Utang jangka dawa NVRO (nevro.com)|RSLS - Utang jangka dawa perusahaan|SILK - Tanggungan utang jangka dawa perusahaan